Health In Tech (HIT) CFO gets 1M restricted shares tied to deals

Rhea-AI Filing Summary

Health In Tech, Inc. officer and director LinLin Qian reported an award of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 under the Health in Tech Equity Incentive Plan at a price of $0 per share. The grant is tied to two proposed issuer transactions, with half of the shares vesting in equal monthly installments over 12 months after the closing of the first transaction and the other half vesting monthly over 12 months after the closing of the second transaction, subject to continued service.

If either transaction does not close within 24 months after January 6, 2026, any unvested shares related to that transaction will be forfeited without consideration. Following this grant, Qian beneficially owns 9,128,555 Class A shares, including 1,119,130 restricted shares and 8,009,425 unrestricted shares, and also holds but does not count here 2,700,000 Class B shares and 711,510 options to purchase Class A shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Qian LinLin

(Last) (First) (Middle)

701 S. COLORADO AVE,

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/06/2026		A		1,000,000(1)	A	$0	9,128,555(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan in connection with two proposed issuer transactions (each, a "Transaction"). Half of the shares vest in equal monthly installments over 12 months starting at the closing of the first Transaction ("First Transaction Shares"). The other half vest in equal monthly installments over 12 months starting at the closing of the second Transaction ("Second Transaction Shares"). Vesting is subject to continued service. If either Transaction does not close within 24 months after January 6, 2026 (the "Grant Date"), unvested shares relating to that Transaction will be automatically forfeited without consideration.

2. Includes 1,119,130 shares of restricted shares of Class A Common Stock and 8,009,425 unrestricted shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

	/s/ LinLin Qian	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Health In Tech (HIT) report for January 6, 2026?

Health In Tech reported that officer and director LinLin Qian received an award of 1,000,000 restricted shares of Class A Common Stock on January 6, 2026 under the company’s equity incentive plan at a price of $0 per share.

How do the 1,000,000 restricted shares granted to Health In Tech CFO vest?

Half of the 1,000,000 restricted Class A shares vest in equal monthly installments over 12 months starting at the closing of the first proposed issuer transaction, and the other half vest monthly over 12 months starting at the closing of the second proposed issuer transaction, in each case subject to continued service.

What happens to the restricted shares if the proposed transactions for HIT do not close?

If either proposed issuer transaction does not close within 24 months after January 6, 2026, all unvested shares tied to that specific transaction will be automatically forfeited without consideration.

How many Health In Tech Class A shares does LinLin Qian own after this transaction?

After the reported grant, LinLin Qian beneficially owns 9,128,555 Class A Common shares, consisting of 1,119,130 restricted shares and 8,009,425 unrestricted shares.

What other Health In Tech securities associated with LinLin Qian are noted but not included in the Class A total?

The disclosure notes but excludes from the Class A total 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

Did LinLin Qian pay cash for the 1,000,000 restricted Health In Tech shares?

No cash payment is indicated; the 1,000,000 restricted Class A shares were reported at a price of $0 per share as an equity incentive grant.